BBS-Bioactive Bone Substitutes OY

ARTEBONE is bone substitute implant based on reindeer bone protein extract. Used in bone healing problems. Clinical trial in end stage. Applying sales lic.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Oulu, Finland
  • Currency EUR
  • Founded March 2003
  • Employees 13
  • Incorporation Type LLC
  • Website bbs-artebone.fi

Company Summary

BBS has developed a bone substitute more than 10 years, the product is complete and the last step is to get a marketing authorization. Application for sale license will be ready iby the end of this year and after thatr we can take a next step - commercialization. For investors this is very attractive stage.

Team

  • MD, PhD, Professor of Orthopaedic Surgery. Founder (2003) of BBS and one of the major shareholders

  • Mikko Viitanen
    Director of Research and operations and Analytics

    M.Sc. (Biochem., Eng.) Joinet BBS in 2006. Has participated in several research projects in the Universities of Oulu and Helsinki, where he gained his special know-how in fermentation processes, protein chemistry and analytical methods, especially immunological methods

  • Director, Chief of Product and Process Development

    M.Sc (Medical Eng.)PhD. Joined BBS in 2006
    • Extensive experiece of biomaterials and bone substitutes
    • Thesis of Ph.D. concerned the BBS product

  • Quality Assurance/Quality Control

    MSc, Chem. Joined BBS in 2006. Has 26 years of experience in the pharmaceutical industry and development (Leiras Schering Oy and Focus Inhalation Oy 1988 - 2003, CTT-Cancer Targeting Technologies Oy 2003 - 2006), in Quality Control, product development/GMP compliance and Quality Assurance.
    • Post graduate studies in industrial pharmacy and in pharmaceutical technology (2004 -).

  • Clinical research manager

    Clinical Research ManagerHelsinki University, Finland, 1993
    Project Manager, Oy Medfiles Ltd (CRO), 1999-2006
    Project Director, Oy Medfiles Ltd (CRO), 2006-2010
    Director of Clinical Research, Bioactive Bone Substitutes Oy, 2014
    ongoing Clinical trial manager, Bioactive Bone Substitutes Oy
    JUN2014-JUL2014 Pharmacist, Responsible Person, Pharmados Oy, Oulu, Finland MAR2014-ongoing Clinical Research Director, Oy Medfiles Ltd, Oulu, Finland

  • Kenneth Sandstöm, M.Sc. Chem.
    Project Manager, Product Development

    M.Sc. Chem. Joined BBS in 2007
    Has 14 year´s of experience in the pharmaceutical industry (Leiras Schering AG, Focus Inhalation Oy, LAB Pharma Oy, 1994 - 2007), as a senior scientist in the inhalation technology product development, in the area of Chemistry, Manufacturing and Control (CMC)

  • Elli Birr
    Assistant, Quality Assurance

    M.Sc. (Biol.), PhD. Joined BBS Ltd in 1999. Has completed her doctorate thesis in the field of molecular genetics and biology at the University of Bielefeld, Germany. As part of her research, Dr. Birr developed a method for isolating the enzyme lysozyme from bacteria, patented by Hoechst AG and used in the food industry. Has been a Researcher at the University of Oulu since 1993, where she has been studying the morphogenic proteins of reindeer.

Advisors

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free